GlucoTrack Inc (GCTK) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $2.53 (+6.30%), Market cap $0.00B, P/E ratio 0.07, 52-week low–high $0.10 ~ $10.59.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Financial statements, price targets, institutional (13F) holdings and related news for GlucoTrack Inc are updated in real time on BlackAll Trade.
GlucoTrack Inc trades at $2.53 (+6.30%). Real-time quotes and charts are available on BlackAll Trade.
GlucoTrack Inc has a market cap of about $0.00B. Its P/E ratio is 0.07.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the